Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-665.19%
operating margin TTM
-524.63%
revenue TTM
689.94 Thousand
revenue per share TTM
0.13$
valuation ratios | |
|---|---|
| pe ratio | -0.19 |
| peg ratio | -0.02 |
| price to book ratio | -0.11 |
| price to sales ratio | 1.26 |
| enterprise value multiple | -0.87 |
| price fair value | -0.11 |
profitability ratios | |
|---|---|
| gross profit margin | 88.45% |
| operating profit margin | -524.63% |
| pretax profit margin | -648.03% |
| net profit margin | -665.19% |
| return on assets | -180.75% |
| return on equity | 65.87% |
| return on capital employed | -177.91% |
liquidity ratios | |
|---|---|
| current ratio | 3.87 |
| quick ratio | 3.87 |
| cash ratio | 3.08 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 71.49 |
| days of payables outstanding | 856.73 |
| cash conversion cycle | -785.23 |
| receivables turnover | 5.11 |
| payables turnover | 0.43 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.03 |
| debt equity ratio | -0.01 |
| long term debt to capitalization | -0.00 |
| total debt to capitalization | -0.01 |
| interest coverage | -2.09 |
| cash flow to debt ratio | -40.76 |
cash flow ratios | |
|---|---|
| free cash flow per share | -4.28 |
| cash per share | 1.81 |
| operating cash flow per share | -4.19 |
| free cash flow operating cash flow ratio | 1.02 |
| cash flow coverage ratios | -40.76 |
| short term coverage ratios | -57.02 |
| capital expenditure coverage ratio | -42.94 |
Frequently Asked Questions
When was the last time Clearside Biomedical, Inc. (NASDAQ:CLSD) reported earnings?
Clearside Biomedical, Inc. (CLSD) published its most recent earnings results on 14-11-2025.
What is Clearside Biomedical, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Clearside Biomedical, Inc. (NASDAQ:CLSD)'s trailing twelve months ROE is 65.87%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Clearside Biomedical, Inc. (CLSD) currently has a ROA of -180.75%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did CLSD's net profit margin stand at?
CLSD reported a profit margin of -665.19% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is CLSD's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.87 in the most recent quarter. The quick ratio stood at 3.87, with a Debt/Eq ratio of -0.01.